|

Narlumosbart Clinical Trials

1 actively recruiting trial

Also known as: Stereotactic Body Radiation Therapy, chemotherapy

Pipeline

Phase 2: 1

Top Sponsors

  • Fudan University1

Indications

  • Stereotactic Body Radiation Therapy (SBRT)1
  • Immunotherapy1
  • NSCLC1
  • Lung Cancer1
  • Cancer1

Other1 trial

The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.